{
  "run_id": "47901e9dfc19",
  "adapter": "mem0-raw",
  "dataset_version": "0.1.0",
  "budget_preset": "constrained-8k",
  "metrics": [
    {
      "name": "action_quality",
      "tier": 3,
      "value": 0.0,
      "details": {
        "action_recommendation_count": 1,
        "method": "pairwise"
      }
    },
    {
      "name": "answer_quality",
      "tier": 2,
      "value": 0.17378472222222222,
      "details": {
        "per_question": [
          {
            "question_id": "cs03_q04_action",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q01_longitudinal",
            "win_rate": 0.2,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "B",
                "fact_score": 0.5
              }
            ]
          },
          {
            "question_id": "cs03_q13_paraphrase",
            "win_rate": 0.2,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "candidate",
                "verdict_raw": "A",
                "candidate_position": "A",
                "fact_score": 1.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q05_negative",
            "win_rate": 0.25,
            "fact_details": [
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              }
            ]
          },
          {
            "question_id": "cs03_q18_temporal",
            "win_rate": 0.16666666666666666,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q19_distractor",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q24_evidence",
            "win_rate": 0.625,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "candidate",
                "verdict_raw": "A",
                "candidate_position": "A",
                "fact_score": 1.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "candidate",
                "verdict_raw": "A",
                "candidate_position": "A",
                "fact_score": 1.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "candidate",
                "verdict_raw": "A",
                "candidate_position": "A",
                "fact_score": 1.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q11_longitudinal",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q12_severity",
            "win_rate": 0.5,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "candidate",
                "verdict_raw": "A",
                "candidate_position": "A",
                "fact_score": 1.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "candidate",
                "verdict_raw": "B",
                "candidate_position": "B",
                "fact_score": 1.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q15_negative",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q17_temporal",
            "win_rate": 0.0625,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "B",
                "fact_score": 0.5
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q21_distractor",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q22_counterfactual",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q03_longitudinal",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the adverse signal is hepatic (ALT/AST elevation), not renal \u2014 kidney function markers remain stable while liver enzymes diverge",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q06_paraphrase",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q07_temporal",
            "win_rate": 0.16666666666666666,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "tie",
                "verdict_raw": "TIE",
                "candidate_position": "A",
                "fact_score": 0.5
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q08_counterfactual",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations appeared progressively over multiple weeks of statin co-administration with onset timing correlating with cumulative exposure duration rather than a single acute event",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q14_paraphrase",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "multi-site signal distribution rules out site-specific confounders as causal explanation",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              },
              {
                "fact": "Site 07 lab equipment issue is not the cause of ALT elevations",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q16_negative",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          },
          {
            "question_id": "cs03_q20_distractor",
            "win_rate": 0.0,
            "fact_details": [
              {
                "fact": "the ALT elevation pattern correlates with statin co-administration timing, not with immune activation or antibody response patterns",
                "winner": "reference",
                "verdict_raw": "A",
                "candidate_position": "B",
                "fact_score": 0.0
              },
              {
                "fact": "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
                "winner": "reference",
                "verdict_raw": "B",
                "candidate_position": "A",
                "fact_score": 0.0
              }
            ]
          }
        ],
        "method": "pairwise"
      }
    },
    {
      "name": "budget_compliance",
      "tier": 1,
      "value": 0.0,
      "details": {
        "total_questions": 24,
        "total_violations": 169,
        "violation_rate": 7.041666666666667,
        "total_tokens": 1328196,
        "avg_tokens_per_question": 55341.5,
        "max_tokens_single_question": 76625,
        "total_wall_time_minutes": 1.71,
        "avg_wall_time_ms": 4263.3,
        "max_wall_time_ms": 5398.0,
        "per_question_timing": [
          {
            "question_id": "cs03_q12_severity",
            "question_type": "severity_assessment",
            "checkpoint": 79,
            "wall_time_ms": 5398.0,
            "total_tokens": 66130,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q08_counterfactual",
            "question_type": "counterfactual",
            "checkpoint": 99,
            "wall_time_ms": 5368.6,
            "total_tokens": 67977,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q02_null",
            "question_type": "null_hypothesis",
            "checkpoint": 46,
            "wall_time_ms": 5187.6,
            "total_tokens": 55431,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q16_negative",
            "question_type": "negative",
            "checkpoint": 99,
            "wall_time_ms": 5080.3,
            "total_tokens": 62059,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q17_temporal",
            "question_type": "temporal",
            "checkpoint": 79,
            "wall_time_ms": 5057.5,
            "total_tokens": 67198,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q20_distractor",
            "question_type": "distractor_resistance",
            "checkpoint": 99,
            "wall_time_ms": 5045.6,
            "total_tokens": 57578,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q11_longitudinal",
            "question_type": "longitudinal",
            "checkpoint": 79,
            "wall_time_ms": 5017.2,
            "total_tokens": 68886,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q15_negative",
            "question_type": "negative",
            "checkpoint": 79,
            "wall_time_ms": 4842.2,
            "total_tokens": 76625,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q19_distractor",
            "question_type": "distractor_resistance",
            "checkpoint": 58,
            "wall_time_ms": 4757.4,
            "total_tokens": 62276,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q04_action",
            "question_type": "action_recommendation",
            "checkpoint": 119,
            "wall_time_ms": 4668.1,
            "total_tokens": 55928,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q03_longitudinal",
            "question_type": "longitudinal",
            "checkpoint": 99,
            "wall_time_ms": 4661.2,
            "total_tokens": 56277,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q06_paraphrase",
            "question_type": "paraphrase",
            "checkpoint": 99,
            "wall_time_ms": 4595.4,
            "total_tokens": 55872,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q07_temporal",
            "question_type": "temporal",
            "checkpoint": 99,
            "wall_time_ms": 4540.7,
            "total_tokens": 50157,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q14_paraphrase",
            "question_type": "paraphrase",
            "checkpoint": 99,
            "wall_time_ms": 4193.7,
            "total_tokens": 68492,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q22_counterfactual",
            "question_type": "counterfactual",
            "checkpoint": 79,
            "wall_time_ms": 4057.9,
            "total_tokens": 56427,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q21_distractor",
            "question_type": "distractor_resistance",
            "checkpoint": 79,
            "wall_time_ms": 3986.4,
            "total_tokens": 40542,
            "tool_calls": 5
          },
          {
            "question_id": "cs03_q01_longitudinal",
            "question_type": "longitudinal",
            "checkpoint": 46,
            "wall_time_ms": 3974.3,
            "total_tokens": 56679,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q23_null",
            "question_type": "null_hypothesis",
            "checkpoint": 79,
            "wall_time_ms": 3840.2,
            "total_tokens": 55168,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q09_longitudinal",
            "question_type": "longitudinal",
            "checkpoint": 18,
            "wall_time_ms": 3532.0,
            "total_tokens": 54900,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q18_temporal",
            "question_type": "temporal",
            "checkpoint": 58,
            "wall_time_ms": 3304.5,
            "total_tokens": 56102,
            "tool_calls": 7
          },
          {
            "question_id": "cs03_q10_evidence",
            "question_type": "evidence_sufficiency",
            "checkpoint": 18,
            "wall_time_ms": 3245.5,
            "total_tokens": 43373,
            "tool_calls": 6
          },
          {
            "question_id": "cs03_q24_evidence",
            "question_type": "evidence_sufficiency",
            "checkpoint": 58,
            "wall_time_ms": 3144.6,
            "total_tokens": 42602,
            "tool_calls": 5
          },
          {
            "question_id": "cs03_q05_negative",
            "question_type": "negative",
            "checkpoint": 58,
            "wall_time_ms": 2899.5,
            "total_tokens": 32452,
            "tool_calls": 4
          },
          {
            "question_id": "cs03_q13_paraphrase",
            "question_type": "paraphrase",
            "checkpoint": 46,
            "wall_time_ms": 1920.0,
            "total_tokens": 19065,
            "tool_calls": 3
          }
        ]
      }
    },
    {
      "name": "citation_coverage",
      "tier": 1,
      "value": 0.0,
      "details": {
        "num_questions": 24
      }
    },
    {
      "name": "evidence_coverage",
      "tier": 1,
      "value": 0.0,
      "details": {
        "num_questions": 24
      }
    },
    {
      "name": "evidence_grounding",
      "tier": 1,
      "value": 1.0,
      "details": {
        "total_retrieved": 6,
        "total_valid": 6
      }
    },
    {
      "name": "fact_recall",
      "tier": 1,
      "value": 0.08333333333333333,
      "details": {
        "num_questions": 24
      }
    },
    {
      "name": "insight_depth",
      "tier": 2,
      "value": 0.041666666666666664,
      "details": {
        "num_questions": 24,
        "multi_episode_questions": 1
      }
    },
    {
      "name": "longitudinal_advantage",
      "tier": 3,
      "value": -0.3490079365079365,
      "details": {
        "synthesis_mean": 0.15099206349206348,
        "control_mean": 0.5,
        "synthesis_count": 21,
        "control_count": 2,
        "method": "pairwise"
      }
    },
    {
      "name": "naive_baseline_advantage",
      "tier": 3,
      "value": 0.21805555555555556,
      "details": {
        "win_rate": 0.092,
        "loss_rate": 0.7931,
        "tie_rate": 0.1149,
        "total_fact_comparisons": 87,
        "per_type": {
          "action_recommendation": 0.5,
          "counterfactual": 0.0,
          "distractor_resistance": 0.0833,
          "evidence_sufficiency": 0.0625,
          "longitudinal": 0.1667,
          "negative": 0.3333,
          "paraphrase": 0.1333,
          "severity_assessment": 0.1875,
          "temporal": 0.1111
        },
        "per_question": [
          {
            "question_id": "cs03_q04_action",
            "question_type": "action_recommendation",
            "win_rate": 0.5,
            "fact_count": 3
          },
          {
            "question_id": "cs03_q01_longitudinal",
            "question_type": "longitudinal",
            "win_rate": 0.0,
            "fact_count": 5
          },
          {
            "question_id": "cs03_q13_paraphrase",
            "question_type": "paraphrase",
            "win_rate": 0.4,
            "fact_count": 5
          },
          {
            "question_id": "cs03_q05_negative",
            "question_type": "negative",
            "win_rate": 0.25,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q18_temporal",
            "question_type": "temporal",
            "win_rate": 0.3333,
            "fact_count": 3
          },
          {
            "question_id": "cs03_q19_distractor",
            "question_type": "distractor_resistance",
            "win_rate": 0.0,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q24_evidence",
            "question_type": "evidence_sufficiency",
            "win_rate": 0.0625,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q11_longitudinal",
            "question_type": "longitudinal",
            "win_rate": 0.5,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q12_severity",
            "question_type": "severity_assessment",
            "win_rate": 0.1875,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q15_negative",
            "question_type": "negative",
            "win_rate": 0.0,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q17_temporal",
            "question_type": "temporal",
            "win_rate": 0.0,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q21_distractor",
            "question_type": "distractor_resistance",
            "win_rate": 0.0,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q22_counterfactual",
            "question_type": "counterfactual",
            "win_rate": 0.0,
            "fact_count": 8
          },
          {
            "question_id": "cs03_q03_longitudinal",
            "question_type": "longitudinal",
            "win_rate": 0.0,
            "fact_count": 5
          },
          {
            "question_id": "cs03_q06_paraphrase",
            "question_type": "paraphrase",
            "win_rate": 0.0,
            "fact_count": 4
          },
          {
            "question_id": "cs03_q07_temporal",
            "question_type": "temporal",
            "win_rate": 0.0,
            "fact_count": 3
          },
          {
            "question_id": "cs03_q08_counterfactual",
            "question_type": "counterfactual",
            "win_rate": 0.0,
            "fact_count": 3
          },
          {
            "question_id": "cs03_q14_paraphrase",
            "question_type": "paraphrase",
            "win_rate": 0.0,
            "fact_count": 4
          },
          {
            "question_id": "cs03_q16_negative",
            "question_type": "negative",
            "win_rate": 0.75,
            "fact_count": 2
          },
          {
            "question_id": "cs03_q20_distractor",
            "question_type": "distractor_resistance",
            "win_rate": 0.25,
            "fact_count": 2
          }
        ],
        "method": "pairwise_vs_naive"
      }
    },
    {
      "name": "reasoning_quality",
      "tier": 2,
      "value": 0.3333333333333333,
      "details": {
        "num_questions": 24,
        "qualified": 8
      }
    }
  ],
  "composite_score": 0.1861961805555556
}